About
Next-Gen Drug Discovery with AI: Molecules to Market is a comprehensive self-paced program designed for pharmaceutical researchers and biotech professionals eager to harness the power of artificial intelligence in drug discovery. This course covers the entire pipeline of AI applications, from target identification to market approval, providing participants with a deep understanding of how AI can revolutionise the drug discovery process. Participants will explore cutting-edge case studies from real-world AI-driven drug discoveries, such as AlphaFold and Insilico Medicine, to understand the practical applications and impact of AI in the field. The program delves into the ethical considerations and compliance essentials necessary for integrating AI into drug development, ensuring that participants are well-versed in the regulatory landscape. By the end of this program, participants will have gained the skills and knowledge to design, optimize, and execute AI-powered clinical trials, making them invaluable assets to their organizations. Whether you are looking to stay ahead in the rapidly evolving pharmaceutical industry or seeking to enhance your expertise in AI-driven drug discovery, this program offers the tools and insights needed to succeed.
You can also join this program via the mobile app. Go to the app